Company Wntresearch AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- SEK | - |
05-03 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Per Norlén
CEO | Chief Executive Officer | 54 | 01-09 |
Founder | 68 | 23/09/07 | |
Anders Tidfors
DFI | Director of Finance/CFO | - | 10/09/20 |
Kicki Johansson
COO | Chief Operating Officer | 66 | 31/12/17 |
Chief Tech/Sci/R&D Officer | 62 | 31/07/16 | |
Corporate Officer/Principal | 56 | 31/12/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 08/06/15 | |
Founder | 68 | 23/09/07 | |
Chairman | 62 | 31/12/21 | |
Gudrun Anstrén
BRD | Director/Board Member | 69 | 14/05/18 |
Director/Board Member | - | - | |
Mats Lindskog
BRD | Director/Board Member | - | 31/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,660,590 | 1,309,629 ( 15.12 %) | 0 | 15.12 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.63% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- WNT Stock
- Stock
- Company Wntresearch AB